Vaccinex, Inc.
(NASDAQ : VCNX)

( )
VCNX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.32%90.401.3%$812.42m
AMGNAmgen Inc.
-0.03%186.921.2%$635.34m
GILDGilead Sciences, Inc.
0.33%66.980.9%$508.19m
BIIBBiogen Inc.
0.65%335.161.3%$445.14m
ILMNIllumina, Inc.
-0.01%302.243.5%$320.02m
REGNRegeneron Pharmaceuticals, Inc.
0.45%422.512.6%$304.29m
VRTXVertex Pharmaceuticals Incorporated
0.52%187.841.9%$269.00m
ALXNAlexion Pharmaceuticals, Inc.
0.71%129.842.0%$236.61m
SRPTSarepta Therapeutics, Inc.
0.22%140.5715.4%$155.25m
AAgilent Technologies, Inc.
1.28%78.511.6%$145.08m
EXASExact Sciences Corporation
-2.27%83.6325.3%$129.45m
INCYIncyte Corporation
-0.40%83.742.5%$115.31m
ARRYArray BioPharma Inc.
0.30%23.178.2%$109.81m
EXELExelixis, Inc.
-0.52%21.246.4%$84.04m
NBIXNeurocrine Biosciences, Inc.
-1.89%79.365.1%$80.57m

Company Profile

Vaccinex, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. It focuses on developing antibody treatments relevant to cancer, inflammation, and auto-immune diseases, as well as products for the treatment of non-small cell lung cancer, osteosarcoma, melanoma and Huntington's diseases. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.